Dr. Charlie In discusses the evolving landscape of impact investing and the opportunities for channeling capital toward the Sustainable Development Goals (SDGs).

Boustead APEX CEO Dr. Marcuz Tan discusses the growing trend of Asian companies listing on U.S. exchanges and the strategic considerations behind these moves.

Four High-Potential Asian Companies Chosen for U.S. IPO Pathway

Three companies selected for U.S. IPO pathway under Boustead APEX, Inc. & Raffles Capital

Boustead APEX, Inc. and Raffles Capital engaged in an insightful fire-side chat during Try Everything 2025.

Boustead APEX, Inc., Asia’s leading U.S. IPO advisory firm, together with its strategic partners including the China Centre for Promoting SME Cooperation and Development (中小企业合作发展促进中心) and international law firm Loeb & Loeb LLP, has successfully completed several major stops of its inaugural China Multi-City IPO Conference including Shenzhen, Beijing, and Shanghai.

Boustead APEX, Inc., in collaboration with international law firm Loeb & Loeb LLP, successfully hosted the Beijing stop of its China-wide IPO Conference series.

Regen Health Care Group, a leading provider of advanced stem cell regeneration therapies, announced today its strategic partnership with Boustead APEX, Inc., Boustead & Co, and cornerstone investor Raffles Capital US to bring the company public in the United States.

Emperor Tea has announced plans to pursue an Initial Public Offering (IPO) in the United States, a major step in its mission to globalise its brand — including entering the U.S. market — and bring the natural herbal goodness of tea to consumers worldwide. The company will be advised by Boustead APEX, Inc.

Boustead APEX, Inc., in partnership with Wan Yi Group, successfully hosted the 2nd Shenzhen IPO Conference (IPOC), attracting over 80 high-growth companies from Shenzhen eager to explore opportunities in the U.S. capital markets. The event brought together leading experts, underwriters, investors, and legal professionals to discuss how Asian companies can efficiently list and thrive on the NYSE and NASDAQ.

Boustead APEX, Inc. kicked off its inaugural China-wide IPO Conference in Shenzhen, the first of multiple city stops that will also include Beijing, Shanghai, and Hangzhou, bringing together entrepreneurs, investors, and market experts to share strategies for profitable growth and stronger positioning for U.S. capital market listings — while preserving founder equity.

Raffles Capital Pte. Ltd. (“RC”) and Raffles Financial Group Limited (“RFG”) issue this official statement in response to recent incidents of false advertising and misrepresentation.

IPO Conference - Asia Edition 2025: Empowering Asia’s Next Generation of Public Companies
BAI is spearheading the IPO Conference - Asia Edition 2025, a landmark event series designed to demystify the IPO journey for Asia-Pacific businesses.

Landmark collaboration between United States-incorporated Raffles SDG Fund and Tai Chuang Yuan Group (TCY) for the launch of the SDG Impact Fund (SIF)

Boustead Apex, Inc. (BAI) today announced its commitment to advancing the plans of two Singapore-based firms, Mottainai and NetZero, to pursue listings on the Tokyo Stock Exchange (TSE)—the world’s third-largest stock exchange, with a market capitalization exceeding USD 6 trillion.

The Future of Talent Acquisition. An AI-Driven Solution to Build Better Teams for Long-Term Success

Meeting Asia’s Energy Needs Sustainably. Investing in Biofuel Production for a Cleaner Future

The Venture Accelerator for Sustainable Growth. Helping Companies Achieve Market Success While Advancing Social Impact

Transforming Recycling for a Greener Tomorrow. Invest in an Innovative Approach to Boost Recycling Efficiency

Protecting the Future with Advanced Cybersecurity. A Strategic Investment in a Military-Grade Cybersecurity Solution